Search clinical trials for: BCD-054 240 mcg
Total 1419 results
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Air Force Military Medical University, China; Jiangsu Province Centers for... and other collaboratorsCompleted
-
University of Cape TownUniversity of Stellenbosch; Seattle Children's Research Institute (SCRI)CompletedHIV Infection | HIV Exposure
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
JhpiegoUniversity of the PhilippinesCompletedCervical DysplasiaPhilippines
-
National Cancer Institute (NCI)Rutgers Cancer Institute of New JerseyCompleted
-
MedImmune LLCAmgenCompletedAsthmaUnited States, Slovakia, Israel, South Africa, Ukraine, Japan, Czechia, Hungary, Bulgaria, Serbia, Latvia, Lithuania
-
Green Signal Biopharma Private LimitedCompleted
-
Bandim Health ProjectTerminated
-
The Netherlands Asthma FoundationCompletedAsthma | Rhinitis | Atopic Dermatitis | Food AllergyNetherlands
-
London School of Hygiene and Tropical MedicineCompletedImmunity, Cellular | Hypersensitivity, Delayed TypeMalawi, United Kingdom
-
Assiut UniversityNot yet recruiting
-
BiocadCompleted
-
Johns Hopkins UniversityCystic Fibrosis FoundationCompletedCystic Fibrosis | Bronchiectasis Adult | Non-Tuberculous MycobacteriaUnited States
-
Radboud University Medical CenterUnknown
-
National Institute of Allergy and Infectious Diseases...Completed
-
AstraZenecaCompleted
-
Verity Pharmaceuticals Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | Bladder Cancer Recurrent | Neoplasm Recurrence | Urothelial Carcinoma Recurrent | Non-Invasive Bladder Urothelial Carcinoma
-
GlaxoSmithKlineCompletedSinusitis, AcuteGermany, Spain, Bulgaria, Czechia, Canada, Sweden, Netherlands, Estonia, Norway, Poland, Ukraine, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Norway
-
Lone Graff StensballeHvidovre University Hospital; Kolding Sygehus; Danish National Research Foundation and other collaboratorsCompletedProspective | Single-blind | Clinical | Trial | InterventionDenmark
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Canada, Philippines, Brazil
-
Vakzine Projekt Management GmbHCompletedHealthy | TuberculosisGermany
-
Radboud University Medical CenterCompletedInnate Immune Response
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingHPV InfectionUnited States
-
BiocadCompletedSeropositive RARussian Federation, Belarus
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Japan, Netherlands, India, Canada, Czechia, Mexico, Australia, Portugal
-
Fisher and Paykel HealthcareCompleted
-
University of OxfordRecruiting
-
Biofabri, S.LUniversity of Stellenbosch; University of Cape Town; TuBerculosis Vaccine Initiative and other collaboratorsRecruitingTuberculosisSouth Africa
-
University of OxfordActive, not recruiting
-
University of CalgaryNot yet recruitingChronic Migraine
-
Tamir Ben-HurHebrew University of JerusalemEnrolling by invitationAlzheimer Disease, Late OnsetIsrael
-
Massachusetts General HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
Murdoch Childrens Research InstituteBill and Melinda Gates Foundation; Royal Children's HospitalCompletedCOVID-19 | Corona Virus Infection | Coronavirus Disease 2019 (COVID-19) | Respiratory IllnessAustralia, Brazil, Netherlands, Spain, United Kingdom
-
BiocadCompletedAnkylosing SpondylitisRussian Federation
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Philippines, Canada, Brazil
-
Children's Hospital Medical Center, CincinnatiUniversity of MichiganTerminatedAcute Kidney InjuryUnited States
-
University of OxfordMRC/UVRI and LSHTM Uganda Research UnitCompleted
-
Bandim Health ProjectUniversity of Southern DenmarkCompletedCOVID-19 | Morbidity | Non-specific Effects of Vaccines | Absenteeism | Heterologous ImmunityDenmark
-
University of OxfordCompleted
-
Ain Shams UniversityUnknownCoronavirus Disease (COVID-19)Egypt
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences LtdRecruitingUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, ImmunologicalChina
-
Radboud University Medical CenterUMC UtrechtActive, not recruitingInfections | COVID-19 | Inflammation | BCG Vaccination ReactionNetherlands
-
University of OxfordUniversity of BirminghamCompleted
-
University of Southern DenmarkEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Centro... and other collaboratorsCompletedCovid19 | Morbidity | AbsenteeismGuinea-Bissau, Mozambique
-
Ankara Training and Research HospitalCompletedDisease Progression | Bladder Cancer | Recurrent Bladder Cancer
-
Serum Institute of India Pvt. Ltd.Active, not recruitingPrevention of TB RecurrenceBangladesh, India
-
ImmunityBio, Inc.Active, not recruitingNon Muscle Invasive Bladder CancerUnited States